PharmExec Direct:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
PharmExec Direct | From the editors of Pharmaceutical Executive Visit the PharmExec website
Send Us Some Feedback
 
January 27, 2011 | ISSUE NUMBER 184 VOL 8

Drug Development
NIH Director On the Consortium’s New Remit
As the National Institutes of Health hits the headlines over its remit to help develop new medicines, Director Francis Collins talks about the new initiatives he sees as critical for innovation, industry, and public health.

Europe
Is Hungary Hungry Enough for Pharma?
Hungary has taken over the chair of the EU Council, but European pharma is unlikely to gain much from its surface enthusiam, writes Reflector.

Regulatory
New Roster of Players to Debate Comparative Effectiveness Standards
Government Accountability Office helps appoint 15 experts to the new Methodology Committee.

Global
Can the Happiness Quotient Build an Economic Case for Pharma?
The latest vogue in economics is the effort to quantify the impact of personal well being on growth and productivity performance. Can it work for pharma?

// The Consumer Healthcare Products Association (Washington, DC) announced that Emily Skor has been selected to serve as Vice President of Communications and Alliance Development. She will begin her work at the association on Feb. 14 // Momenta Pharmaceuticals (Cambridge, Mass.), a biotechnology company specializing in the characterization and engineering of complex drugs, announced the appointment of Thomas P. Koestler, PhD, to its Board of Directors. // OSO BioPharmaceuticals Manufacturing (Albuquerque, NM) has named Craig Mastenbaum as Director of New Business Development for its West Coast market. // Stuart W. Peltz, Ph.D., President and CEO of PTC Therapeutics (South Plainfield, NJ), was elected a Fellow of the American Association for the Advancement of Science. // The International Partnership for Microbicides (Silver Spring, MD) announced the appointment of Dr. Peter B. Corr as Chair of its Board of Directors, as well as new Board members Georgina Caswell and Dr. Florence W. Manguyu. Dr. Brid Devlin has been appointed Executive Vice President for Product Development. // 3D Communications (Washington, DC) announced that Virginia Cox will join its team of healthcare experts on Feb. 1.
 

Feb 1–2: Pharma Market Research
Parsippany, NJ


May 5: Healthcare Businesswomen’s Association Woman of the Year
Fairfield, NJ


March 22-23: iPharma Connect—Digitally Connecting with Patients, Physicians, and Payers
Philadelphia, PA


 

 
FindPharma  
Search  

Survey
What should pharma’s relationship with patients be?
Click To Vote
 
 
Quick Links

J&J Recalls More Medicines

Managing Clinical Trials in Emerging Markets

The Right Marketing Mix for 2011


Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook

User Management
| Subscribe | Update My Profile | Send Feedback | Advertise With Us | Visit PharmExec.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your Inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit Pharmaceutical Executive